Uirusu最新文献_第5页

[One hundred million years history of bornavirus infection]. [1亿年的冠状病毒感染史]。

Uirusu Pub Date : 2022-01-01 DOI: 10.2222/jsv.72.47

Masayuki Horie

引用次数: 0

Uirusu Pub Date : 2022-01-01 DOI: 10.2222/jsv.72.63

Koji Yahara

引用次数: 0

[Comprehensive understanding of viral diseases by field, molecular, and theoretical studies]. [通过领域、分子和理论研究全面了解病毒性疾病]。

Uirusu Pub Date : 2022-01-01 DOI: 10.2222/jsv.72.87

Yuki Furuse

{"title":"[Comprehensive understanding of viral diseases by field, molecular, and theoretical studies].","authors":"Yuki Furuse","doi":"10.2222/jsv.72.87","DOIUrl":"https://doi.org/10.2222/jsv.72.87","url":null,"abstract":"Viral diseases are responsible for substantial morbidity and mortality and continue to be of great concern. To ensure better control of viral infections, I have been tackling the issue as a medical doctor, an academic researcher, and a public health officer. Especially, I have studied respiratory viruses, such as the influenza virus, from the perspectives of molecular virology, theoretical modeling, and field epidemiology. RNA biology and its involvement with viral life-cycle and pathogenicity are central topics of molecular study, while mathematical models of transmission dynamics and phylogenetics are major components of theoretical research. As a field epidemiologist, I work with public health authorities during viral disease outbreaks. I was deployed to West Africa for viral hemorrhagic fever outbreak responses as a WHO consultant, and I have served the Japanese Government as an advisor for COVID-19 countermeasures. I would like to integrate various approaches from clinical medicine to epidemiology, theoretical modeling, evolutionary biology, genetics, and molecular biology in my research. In that way, we could gain a more comprehensive understanding of viral diseases. I hope these findings will help ease the disease burden of viral infections around the world.","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"72 1","pages":"87-92"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71415854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Reverse genetics systems for Reoviridae viruses]. [呼肠孤病毒科病毒的反向遗传系统]。

Uirusu Pub Date : 2022-01-01 DOI: 10.2222/jsv.72.55

Yuta Kanai, Ryotaro Nouda, Takeshi Kobayashi

引用次数: 0

[Developing a Biosafety Level 4 Laboratory user training program]. [制定生物安全 4 级实验室用户培训计划]。

Uirusu Pub Date : 2022-01-01 DOI: 10.2222/jsv.72.125

Asuka Nanbo, Shuzo Urata, Yoshimi Tsuda

{"title":"[Developing a Biosafety Level 4 Laboratory user training program].","authors":"Asuka Nanbo, Shuzo Urata, Yoshimi Tsuda","doi":"10.2222/jsv.72.125","DOIUrl":"https://doi.org/10.2222/jsv.72.125","url":null,"abstract":"In recent years, numerous emerging and reemerging infectious diseases have occurred worldwide and have seriously threatened our society. As a countermeasure against the pathogens responsible for serious diseases (classified as class 4 pathogens), we are preparing for full operation of the first suit-type biosafety level 4 (BSL-4) facility available for basic and applied research at Nagasaki University. For the safe operation of these facilities, experienced and qualified personnel with appropriate skills and knowledge of biorisk management must be certified. Developing an appropriate training system is a prerequisite for ensuring the safety of users involved in research in a BSL-4 laboratory. Here, we introduce an overview of the content of the training program that we are currently establishing for the BSL-4 facility at Nagasaki University. We are designing this program to follow national and international guidelines and regulations in part by referring to experiences and materials derived from multiple BSL-4 facilities in other countries. The established training program system, including the formulation processes, will serve as a reference and will provide practical materials for other research organizations to develop their own high-containment laboratory training programs.","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"72 2","pages":"125-130"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Isolation of anti-SARS-CoV-2 neutralizing monoclonal antibodies cross effective to variants aiming at antibody therapy]. [抗sars - cov -2中和性单克隆抗体与针对抗体治疗的变异交叉有效的分离]。

Uirusu Pub Date : 2021-01-01 DOI: 10.2222/jsv.71.163

引用次数: 0

[Infectivity-enhancing antibodies against SARS-CoV-2]. [抗SARS-CoV-2感染增强抗体]。

Uirusu Pub Date : 2021-01-01 DOI: 10.2222/jsv.71.169

引用次数: 2

[The latest research findings on Ebola virus]. [埃博拉病毒的最新研究结果]。

Uirusu Pub Date : 2021-01-01 DOI: 10.2222/jsv.71.137

引用次数: 0

[Yezo virus and emerging orthonairovirus diseases]. [叶佐病毒和新出现的原鼻病毒疾病]。

Uirusu Pub Date : 2021-01-01 DOI: 10.2222/jsv.71.117

Keita Matsuno

引用次数: 2

Uirusu Pub Date : 2021-01-01 DOI: 10.2222/jsv.71.185

引用次数: 0